Recent research uncovers strong correlations between gut bacteria composition and physical function in seniors, suggesting microbiome-targeted interventions could combat frailty. Can the bacteria in y...
New research links exercise-induced gut microbiome changes to better physical function in seniors, suggesting personalized probiotics could enhance healthy aging. Regular moderate activity boosts bene...
A March 2025 study shows mild acidosis increases frailty risk by 40% in seniors with normal kidney function, pointing to dietary interventions and alkali supplementation. A March 2025 study found low ...
Recent studies uncover ATF5’s role in aging muscle, offering insights into sarcopenia but cautioning against direct targeting, with research pivoting to alternative strategies for improved muscl...
Muscle-generated exerkines in extracellular vesicles are crucial for exercise-induced health, with new research suggesting therapies for sarcopenia and metabolic diseases through inter-organ communica...
Recent studies reveal MG53 (TRIM72) enhances muscle stem cell activation and reduces inflammation, offering a novel therapeutic target for sarcopenia with promising preclinical and early clinical resu...
Recent UK Biobank data reveals myostatin variants boosting muscle mass, with research accelerating on combining inhibitors with GLP-1 drugs to combat sarcopenia, highlighting ethical debates in therap...
Exploring recent advances in senolytic and senomorphic therapies, including dasatinib-quercetin and immune-based approaches, to combat age-related diseases like Alzheimer’s and sarcopenia. New t...
Recent studies reveal that supplementing Roseburia inulinivorans enhances muscle strength by up to 30% in mice, with human trials showing promise for probiotic therapies against sarcopenia. New resear...
Recent studies show Roseburia inulinivorans boosts muscle strength in aging, with probiotics targeting sarcopenia gaining traction in the wellness market amid regulatory and ethical debates. Breakthro...
